Cernostics, Deciphex to Collaborate on AI-Based Histology in Barrett's Esophagus

Sep 10, 2020

|

NEW YORK — Cernostics has partnered with Irish digital pathology firm Deciphex to study the use of artificial intelligence (AI)-based image analysis for the early detection of cancer in Barrett's esophagus patients, the companies said on Thursday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Cernostics, Deciphex to Collaborate on AI-Based Histology in Barrett's Esophagus

To read the full story....

Breaking News

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

FDA Authorizes First COVID-19 Serology Test for Point-of-Care Use

United Airlines Launches COVID-19 Testing Program for Travelers to Hawaii

Babson Diagnostics Raises $13.7M In Series A Financing

FDA Grants Emergency Use Authorizations for Quadrant Biosciences, KimForest Coronavirus Tests

BARDA Awards $684K to Luminex for Enhanced COVID-19 Multiplex Antibody Test

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

What's Popular?

UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

JP Morgan Downgrades Illumina to Neutral on Grail Deal

Illumina to Acquire Grail for $8B in Cash and Stock

Sponsorships